483
Eisai, Inc.Eisai, Inc. – FDA 483, Feb 16, 2018
Record Details
Eisai, Inc. in Woodcliff Lake, NJ, was cited for significant deficiencies in clinical trial data management and access control during an FDA inspection. The firm failed to adhere to its investigational plan, protocols, and internal procedures, leading to unauthorized access to unblinded study data and improper user access management for clinical databases. These issues indicate a serious breakdown in data integrity and protocol compliance for multiple studies.
View Company Profile
ID · 589d69b0-e1da-4820-8438-7f8b469d31af
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.